» Articles » PMID: 37175705

Association Between Taxonomic Composition of Gut Microbiota and Host Single Nucleotide Polymorphisms in Crohn's Disease Patients from Russia

Abstract

Crohn's disease (CD) is a chronic relapsing inflammatory bowel disease of unknown etiology. Genetic predisposition and dysbiotic gut microbiota are important factors in the pathogenesis of CD. In this study, we analyzed the taxonomic composition of the gut microbiota and genotypes of 24 single nucleotide polymorphisms (SNP) associated with the risk of CD. The studied cohorts included 96 CD patients and 24 healthy volunteers from Russia. Statistically significant differences were found in the allele frequencies for 8 SNPs and taxonomic composition of the gut microbiota in CD patients compared with controls. In addition, two types of gut microbiota communities were identified in CD patients. The main distinguishing driver of bacterial families for the first community type are and unclassified members of the order, and the second type is characterized by increased abundance of and . Differences in the allele frequencies of the rs9858542 (), rs3816769 (), and rs1793004 () were also found between groups of CD patients with different types of microbiota communities. These findings confirm the complex multifactorial nature of CD.

Citing Articles

Contribution of the Gut Microbiome to the Perpetuation of Inflammation in Crohn's Disease: A Systematic Review.

Paidimarri S, Ayuthu S, Chauhan Y, Bittla P, Mirza A, Saad M Cureus. 2024; 16(8):e67672.

PMID: 39314611 PMC: 11419584. DOI: 10.7759/cureus.67672.


Two-Year Study on the Intra-Individual Dynamics of Gut Microbiota and Short-Chain Fatty Acids Profiles in Healthy Adults.

Senina A, Markelova M, Khusnutdinova D, Siniagina M, Kupriyanova O, Synbulatova G Microorganisms. 2024; 12(8).

PMID: 39203554 PMC: 11357285. DOI: 10.3390/microorganisms12081712.


Research advancements and perspectives of inflammatory bowel disease: A comprehensive review.

Bai J, Wang Y, Li F, Wu Y, Chen J, Li M Sci Prog. 2024; 107(2):368504241253709.

PMID: 38778725 PMC: 11113063. DOI: 10.1177/00368504241253709.

References
1.
Netz U, Carter J, Eichenberger M, Dryden G, Pan J, Rai S . Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease. World J Gastroenterol. 2017; 23(27):4958-4967. PMC: 5526766. DOI: 10.3748/wjg.v23.i27.4958. View

2.
Imhann F, Vich Vila A, Bonder M, Fu J, Gevers D, Visschedijk M . Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2016; 67(1):108-119. PMC: 5699972. DOI: 10.1136/gutjnl-2016-312135. View

3.
Lu X, Tao Y, Wu C, Zhao P, Li K, Zheng J . Association between variants of the autophagy related gene--IRGM and susceptibility to Crohn's disease and ulcerative colitis: a meta-analysis. PLoS One. 2013; 8(11):e80602. PMC: 3827440. DOI: 10.1371/journal.pone.0080602. View

4.
Pittayanon R, Lau J, Leontiadis G, Tse F, Yuan Y, Surette M . Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology. 2019; 158(4):930-946.e1. DOI: 10.1053/j.gastro.2019.11.294. View

5.
Laserna-Mendieta E, Salvador-Martin S, Arias A, Lopez-Cauce B, Marin-Jimenez I, Menchen L . Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease. Biomed Pharmacother. 2023; 159:114225. DOI: 10.1016/j.biopha.2023.114225. View